Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients ...Middle East

PR Newswire - News
Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., March 28, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced topline...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients )

    Apple Storegoogle play

    Also on site :



    Latest News